Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 1541

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 7
Chunk 1541
---
 (2,410,879
    )
     
    $
    403,780

    WEIGHTED AVERAGE SHARES OUTSTANDING

    Basic

    4,481,692

    7,688,260

    Diluted

    4,481,692

    7,719,699

    BASIC AND DILUTED NET INCOME (LOSS) PER SHARE

    Basic
     
    $
    (0.54
    )
     
    $
    0.05

    Diluted
     
    $
    (0.54
    )
     
    $
    0.05

The accompanying notes
are an integral part of the consolidated financial statements.

F-4

OSR HOLDINGS, INC.

(f/k/a Bellevue Life Sciences Acquisition Corp.)

CONSOLIDATED STATEMENTS
OF CHANGES IN STOCKHOLDERS’ DEFICIT

FOR THE YEARS ENDED
DECEMBER 31, 2024 AND 2023

    Additional  
       
    Total 

    Common Stock  
    Paid-in  
    Accumulated  
    Stockholders’ 

    Shares  
    Amount  
    Capital  
    Deficit  
    Deficit 
  
    Balance, December 31, 2022 
     1,725,000  
    $173  
    $24,827  
    $(62,508) 
    $(37,508)
  
    Sale of 430,000 Private Placement Units 
     430,000  
     43  
     4,299,957  
     -  
     4,300,000 
  
    Fair value of warrants and rights included in the Units sold in the Initial Public Offering and in the exercise of the over-allotment 
     -  
     -  
     1,236,527  
     -  
     1,236,527 
  
    Accretion of common stock to redemption value 
     -  
     -  
     (5,561,311) 
     (3,888,323) 
     (9,449,634)
  
    Excise tax payable attributable to redemption of common stock 
     -  
     -  
     -  
     (359,957) 
     (359,957)
  
    Net